Litigation

Recent Posts

Zoloft® & SSRIs: The Plaintiffs’ Perspective - An HB Law & Science Conference Report
Posted on 22 Aug 2011 by HB Litigation Conferences

Two major classes of drugs recently have been the subject of mass tort litigation for their alleged tendency to cause birth defects. The first group includes Topamax® and Topiramate, used to treat migraines, and the second comprises Zoloft® and... Read More

$4 Million Awarded In 1st Pa. Trial Alleging Birth Defect From Topamax Epilepsy Drug
Posted on 31 Oct 2013 by Tom Moylan

PHILADELPHIA — (Mealey’s) A Pennsylvania jury on Oct. 30 found that Janssen Pharmaceuticals Inc. failed to warn about the risk of birth defects from its Topamax epilepsy drug and awarded the injured minor $4 million in damages (April Czimmer... Read More

Pennsylvania State Court Jury Awards $10 Million In 2nd Topamax Birth Defect Trial
Posted on 20 Nov 2013 by Tom Moylan

PHILADELPHIA — (Mealey’s) A Pennsylvania state court jury on Nov. 18 awarded more than $10 million to a family whose son was born with a cleft palate allegedly caused by his mother’s use of the antiepileptic drug Topamax during pregnancy... Read More

Janssen Settles Some Pa. Topamax Birth Defect Cases, Will Appeal $3M Verdict
Posted on 11 Mar 2014 by Tom Moylan

PHILADELPHIA — (Mealey’s) Topamax manufacturer Janssen Pharmaceuticals on March 10 said it will appeal a $3 million March 7 birth defect verdict in the Philadelphia County Common Pleas Court even though it reached an agreement to resolve a... Read More